Hyperhomocysteinemia in End Stage Renal Disease: Is Treatment Necessaryn

Hyperhomocysteinemia in End Stage Renal Disease: Is Treatment Necessaryn


Identification: nnj_ma02A2
Issue: March-April 2002
Volume: Vol. 29, No. 2

Standard: $30.00

Description

This article is available to members for free.

Goal: To discuss the pathophysiology, current research, and treatment of hyperhomocysteinemia in patients with kidney disease.

Objectives:

  1. Explain homocystein metabolism and list causes of hyperhomocysteinemia.
  2. Describe the relationship between hyperhomocysteinemia and arterios clerosis.
  3. Discuss hyperhomocysteinemia in patients with kidney disease.
  4. Identify therapeutic strategies to reduce hyperhomocysteinemia.


Author(s)

Credits

Credits: None available.

You must be logged in and own this product in order to post comments.

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content
token-index
token-content